ICAM1 and neoplasm: Many tumour cells evade the immune system by downmodulating MHC molecules and other proteins involved in antigen presentation and target cell recognition.20 Indeed, HMLER-derived CSC-like cells expressed lower levels of MHC class I and of CD54 (ICAM-1) on the cell surface than non-CSCs (Figure 3b), thereby possibly explaining their relative resistance to CD8+ T-cell-mediated killing.